Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
Asymmetrex® stands out due to its patented kinetic stem cell counting (KSC) method, first published in 2020. This technology enables the ac...
Comments Off on Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
October 8, 2024
